Skip to main content
. 2016 Oct-Dec;19(4):505–509. doi: 10.4103/0972-2327.192389

Figure 1.

Figure 1

Comparison of disability (expanded disability status score) between anti-myelin oligodendrocyte glycoprotein and anti-aquaporin-4 antibody patients